Lan Xiaopeng, Feng Mei, Chen Lili, Zhang Luchen, Han Chao, Wang Yizhen, Zheng Jilu, Wang Xiaoyan, Liu Chunlei, Liu Ranlu
Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China.
Discov Oncol. 2024 Aug 23;15(1):366. doi: 10.1007/s12672-024-01249-w.
Increasing research efforts are focused on studying the synthesis and mechanisms of nanomedicine in urologic cancer. We performed a bibliometric study of the literature on nanomedicine in urologic cancer over the last 23 years, focusing on aspects such as researchers, institutions, nations, and keywords. We searched for papers in the Web of Science Core Collection from January 1, 2001, to December 29, 2023. Only reviews and original articles written in English were considered. A total of 2386 papers satisfied the given criteria for inclusion. The publications included in the study originated from 90 nations. The United States had the largest number of published papers, accounting for more than 31.01% of the total. The leading institution in this field is the Chinese Academy of Sciences, with a publishing output of 2.35%. Farokhzad, Omid C., is the most prolific author, with 21 articles, and has garnered the most citations, totaling 6271. The latest phrase to enter the top ten most common lists was "gold nanoparticles." We searched for papers in the Web of Science Core Collection from January 1, 2000, to November 28, 2023. Only reviews and original articles written in English were considered. This is the first bibliometric study of nanomedicine in urologic cancer. This article provides a comprehensive analysis of the current state of research on nanomedicine in urologic cancer over the last 23 years. On the basis of this study, future researchers can identify noteworthy publications, journals, and potential collaborators and explore cutting-edge research directions.
越来越多的研究工作集中在泌尿生殖系统癌症纳米医学的合成及作用机制研究上。我们对过去23年泌尿生殖系统癌症纳米医学的文献进行了文献计量学研究，重点关注研究人员、机构、国家和关键词等方面。我们在科学网核心合集数据库中检索了2001年1月1日至2023年12月29日期间的论文。仅纳入英文撰写的综述和原创文章。共有2386篇论文符合纳入标准。该研究纳入的出版物来自90个国家。美国发表的论文数量最多，占总数的31.01%以上。该领域的领先机构是中国科学院，发表量为2.35%。奥米德·C·法罗赫扎德是发文量最多的作者，有21篇文章，且被引次数最多，总计6271次。进入十大最常见列表的最新词汇是“金纳米颗粒”。我们在科学网核心合集数据库中检索了2000年1月1日至2023年11月28日期间的论文。仅纳入英文撰写的综述和原创文章。这是泌尿生殖系统癌症纳米医学的首次文献计量学研究。本文对过去23年泌尿生殖系统癌症纳米医学的研究现状进行了全面分析。基于这项研究，未来的研究人员可以识别值得关注的出版物、期刊和潜在合作者，并探索前沿研究方向。
